List of diseases covered by
Hereditary Spastic Paraplegia NGS panel
| Gene | Condition |
| AMACR | Alpha-methylacyl-CoA racemase deficiency; Bile acid synthesis defect, congenital, 4 |
| ALDH18A1 | Cutis laxa, autosomal dominant 3; Cutis laxa, autosomal recessive, type IIIA; Spastic paraplegia 9A, autosomal dominant; Spastic paraplegia 9B, autosomal recessive |
| ARG1 | Argininemia |
| ATL1 | Spastic paraplegia 3A, autosomal dominant; Neuropathy, hereditary sensory, type ID |
| AP4B1 | Spastic paraplegia 47, autosomal recessive |
| AP4E1 | Spastic paraplegia 51, autosomal recessive |
| AP4M1 | Spastic paraplegia 50, autosomal recessive |
| AP4S1 | Spastic paraplegia 52, autosomal recessive |
| AP5Z1 | Spastic paraplegia 48, autosomal recessive |
| B4GALNT1 | Spastic paraplegia 26, autosomal recessive |
| BSCL2 | Encephalopathy, progressive, with or without lipodystrophy; Lipodystrophy, congenital generalized, type 2; Neuropathy, distal hereditary motor, type VA; Silver spastic paraplegia syndrome |
| CYP7B1 | Spastic paraplegia 5A, autosomal recessive; |
| CYP2U1 | Spastic paraplegia 56, autosomal recessive |
| CYP27A1 | Cerebrotendinous xanthomatosis |
| DDHD1 | Spastic paraplegia 28, autosomal recessive |
| DDHD2 | Spastic paraplegia 54, autosomal recessive |
| ERLIN2 | Spastic paraplegia 18, autosomal recessive |
| FA2H | Spastic paraplegia 35, autosomal recessive |
| GBA2 | Spastic paraplegia 46, autosomal recessive |
| GJC2 | Spastic paraplegia 44, autosomal recessive; Leukodystrophy, hypomyelinating, 2; Lymphedema, hereditary, IC |
| HSPD1 | Spastic paraplegia 13, autosomal dominant; Leukodystrophy, hypomyelinating, 4 |
| KIF1A | Spastic paraplegia 30, autosomal recessive; Mental retardation, autosomal dominant 9; Neuropathy, hereditary sensory, type IIC |
| KIF5A | Spastic paraplegia 10, autosomal dominant; Amyotrophic lateral sclerosis, susceptibility to, 25; Myoclonus, intractable, neonatal |
| L1CAM | CRASH syndrome; Corpus callosum, partial agenesis of; Hydrocephalus due to aqueductal stenosis |
| MTHFR | Homocystinuria due to MTHFR deficiency |
| NIPA1 | Spastic paraplegia 6, autosomal dominant |
| PAH | Phenylketonuria; [Hyperphenylalaninemia, non-PKU mild] |
| PEX1 | Heimler syndrome 1; Peroxisome biogenesis disorder 1A (Zellweger); Peroxisome biogenesis disorder 1B (NALD/IRD) |
| PLA2G6 | Infantile neuroaxonal dystrophy 1; Neurodegeneration with brain iron accumulation 2B; Parkinson disease 14, autosomal recessive |
| PLP1 | Spastic paraplegia 2, X-linked; Pelizaeus-Merzbacher disease |
| PNPLA6 | Spastic paraplegia 39, autosomal recessive; Boucher-Neuhauser syndrome; Oliver-McFarlane syndrome |
| REEP1 | Spastic paraplegia 31, autosomal dominant; Neuronopathy, distal hereditary motor, type VB |
| RTN2 | Spastic paraplegia 12, autosomal dominant |
| SLC16A2 | Allan-Herndon-Dudley syndrome |
| SLC25A15 | Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome |
| SPART | Troyer syndrome |
| SPAST | Spastic paraplegia 4, autosomal dominant |
| SPG7 | Spastic paraplegia 7, autosomal recessive |
| SPG11 | Spastic paraplegia 11, autosomal recessive; Amyotrophic lateral sclerosis 5, juvenile; Charcot-Marie-Tooth disease, axonal, type 2X |
| SPG21 | Mast syndrome |
| TECPR2 | Spastic paraplegia 49, autosomal recessive |
| VPS37A | Spastic paraplegia 53, autosomal recessive |
| WASHC5 | Spastic paraplegia 8, autosomal dominant; Ritscher-Schinzel syndrome 1 |
| ZFYVE26 | Spastic paraplegia 15, autosomal recessive |

